The objective of this research proposal is to elucidate the stages of the ontogeny of dopaminergic and associated neuronal systems in the striatum and substantia nigra of the rat and to investigate the interactions between these neuronal systems during development. This will provide information on the role of these interactions in regulating and controlling neuronal development. This study will focus on the nigrostriatal dopaminergic pathway and on neuronal systems known to interact with this pathway in development or in the adult rat. There are two aspects to the proposal. First, basic studies on the development of neuronal systems will be done, concentrating on neurotransmitter receptors as markers for development of individual neuronal systems. The receptors of particular interest are dopamine D1 and D2, serotonin S2, cholinergic muscarinic, opiatergic mu and neurotensin receptors. Other markers will also be examined, including dopamine content, high-affinity choline uptake and enkephalin levels. Second, procedures will be used to perturb normal development of particular parts of the system. The effects of these perturbations on the development of other neuronal systems will be examined to investigate the importance of interactions between the neuronal systems for each other's development. The proposed research utilizes quantitative light microscopic autoradiography combined with biochemical pharmacological techniques as an approach that allows examination of the normal development of neurotransmitter systems and examination of the changes induced in that development by interference with normal neuronal interactions in a quantitative manner at very high resolution. This will, in turn, provide a basis for further studies on the effects of xenobiotic agents, such as drugs or environmental pollutants, on the development of the central nervous system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS023975-01
Application #
3408150
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1986-07-01
Project End
1989-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Coulter, C L; Happe, H K; Murrin, L C (1997) Dopamine transporter development in postnatal rat striatum: an autoradiographic study with [3H]WIN 35,428. Brain Res Dev Brain Res 104:55-62
Coulter, C L; Happe, H K; Murrin, L C (1996) Postnatal development of the dopamine transporter: a quantitative autoradiographic study. Brain Res Dev Brain Res 92:172-81
Happe, H K; Murrin, L C (1995) In situ hybridization analysis of CHOT1, a creatine transporter, in the rat central nervous system. J Comp Neurol 351:94-103
Coulter, C L; Happe, H K; Bergman, D A et al. (1995) Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55. Brain Res 690:217-24
Happe, H K; Peters, J L; Bergman, D A et al. (1994) Localization of nicotinic cholinergic receptors in rat brain: autoradiographic studies with [3H]cytisine. Neuroscience 62:929-44
Happe, H K; Murrin, L C (1993) High-affinity choline transport sites: use of [3H]hemicholinium-3 as a quantitative marker. J Neurochem 60:1191-201
Happe, H K; Murrin, L C (1992) High-affinity choline transport regulation by drug administration during postnatal development. J Neurochem 58:2053-9
Happe, H K; Murrin, L C (1992) Development of high-affinity choline transport sites in rat forebrain: a quantitative autoradiography study with [3H]hemicholinium-3. J Comp Neurol 321:591-611
Simonneaux, V; Happe, H K; Ebadi, M et al. (1991) Autoradiographic localization of dopaminergic and noradrenergic receptors in the bovine pineal gland. J Neurochem 57:1796-802
Simonneaux, V; Murrin, L C; Ebadi, M (1990) Characterization of D1 dopamine receptors in the bovine pineal gland with [3H]SCH 23390. J Pharmacol Exp Ther 253:214-20

Showing the most recent 10 out of 18 publications